India Pharma
-
{
- All
- News
- Videos
- Web Stories
-
Centre Asks States To Allocate More LPG To Key Industries Amid Iran Conflict
The Centre also asked states to communicate the new gas and petroleum distribution order to relevant departments.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
The bigger picture threatens a move away from established production hubs like India.
-
India Set To Get Dengue Vaccine Qdenga Soon: Doctors Explain What To Expect
India is set to get a dengue vaccine named Qdenga to tackle the disease burden that it poses. Dr Rashmi Khadapkar and Dr Neha Rastogi explain what people can expect from this announcement.
-
India Pharmaceutical Sector Aims To Make India A Global Innovation Hub In 2026
New Delhi, March 30 (IANS) India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based growth to value and rese
-
Iran War Impact: Hospital Bills, Medicines Could Soon Cost More In India
India's medical devices and pharma sectors import a large share of raw materials, active ingredients and specialised components
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
Sensex Opens Nearly 200 Points Lower, Nifty In Red Too
Sectorally, Nifty Auto, Bank, Financial Services, FMCG, Metal, Pharma, Realty, Oil & Gas opened in red.
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Centre Asks States To Allocate More LPG To Key Industries Amid Iran Conflict
The Centre also asked states to communicate the new gas and petroleum distribution order to relevant departments.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
The bigger picture threatens a move away from established production hubs like India.
-
India Set To Get Dengue Vaccine Qdenga Soon: Doctors Explain What To Expect
India is set to get a dengue vaccine named Qdenga to tackle the disease burden that it poses. Dr Rashmi Khadapkar and Dr Neha Rastogi explain what people can expect from this announcement.
-
India Pharmaceutical Sector Aims To Make India A Global Innovation Hub In 2026
New Delhi, March 30 (IANS) India’s pharmaceutical sector is set to take a major step towards becoming an innovation-driven global powerhouse, as India Pharma 2026 aims to accelerate the industry’s transition from volume-based growth to value and rese
-
Iran War Impact: Hospital Bills, Medicines Could Soon Cost More In India
India's medical devices and pharma sectors import a large share of raw materials, active ingredients and specialised components
-
India Cracks Down On Ads For Weight-Loss Drugs Like GLP-1 In New Advisory
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates drug laws and could attract regulatory action.
-
Sensex Opens Nearly 200 Points Lower, Nifty In Red Too
Sectorally, Nifty Auto, Bank, Financial Services, FMCG, Metal, Pharma, Realty, Oil & Gas opened in red.
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
